Mesenchymal stromal cells have been the subject of an expanding number of studies over
the past decades. Today, over 75,000 publications are available that shine light on the …

Abstract Objective Microvesicles (MVs) are plasmalemmal vesicles that are released from
various cells and regarded as a mediator of intermolecular communication. In present study …

Simple Summary The most common cause of late allograft failure is chronic active antibody-
mediated rejection (ABMR), but no effective therapy is available. Different …

Mesenchymal stromal cells (MSCs) are multipotent and self-renewing cells that reside
essentially in the bone marrow as a non-hematopoietic cell population, but may also be …

Application of mesenchymal stromal cells (MSCs) has been proposed for solid organ
transplantation based on their potent immuno-modulatory effects in vitro and in vivo. We …

Background In former studies we showed in a rat model of renal transplantation that
Mesenchymal Stromal Cells (MSC) prevent acute rejection in an independent way of their …

Chronic kidney disease (CKD) is a progressive and debilitating disease in cats and dogs
with no known cure. Although medical management may be effective initially in stabilizing a …

Despite excellent short‐term graft survival after renal transplantation, the long‐term graft
outcome remains compromised. It has become evident that a combination of sustained …

Background Chronic allograft rejection remains as the leading cause of the chronic renal
grafts loss post-transplantation. No therapy has been found really effective to prevent and …

Background aims Chronic kidney disease (CKD) attributed to cisplatin is well documented.
Mesenchymal stromal cells (MSCs) are proven to be renotropic. Although they have been …